The Current Ratio as of November 2024 (TTM) for ChitogenX Inc. (CHNXF) is 0.02

According to ChitogenX Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.02. This represents a change of -59.60% compared to the average of 0.06 of the last 4 quarters.

ChitogenX Inc. (CHNXF) Historical Current Ratio (quarterly & annually)

How has CHNXF Current Ratio performed in the past?

The mean historical Current Ratio of ChitogenX Inc. over the last ten years is 1.05. The current 0.02 Current Ratio has changed 124.60% with respect to the historical average. Over the past ten years (40 quarters), CHNXF's Current Ratio was at its highest in in the July 2021 quarter at 3.43. The Current Ratio was at its lowest in in the April 2015 quarter at 0.

ChitogenX Inc. (CHNXF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ChitogenX Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ChitogenX Inc. (CHNXF) Average Current Ratio

How has CHNXF Current Ratio performed in the past?

The current Current Ratio of ChitogenX Inc. (CHNXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ChitogenX Inc. (CHNXF) Current Ratio vs. Peers

How is CHNXF’s Current Ratio compared to its peers?

ChitogenX Inc.’s Current Ratio is greater than Advanced Proteome Therapeutics Corporation (0), less than Cellectis S.A. (1.78), less than Biotron Limited (0.58), greater than Bioasis Technologies Inc. (0), less than Ceapro Inc. (7.10), greater than Mymetics Corporation (0.00), less than ProtoKinetix, Incorporated (0.08), less than Statera Biopharma, Inc. (0.37), less than IMV Inc. (0), less than Forward Pharma A/S (0), greater than Lipella Pharmaceuticals Inc. (0), less than Senti Biosciences, Inc. (117.44), less than Fennec Pharmaceuticals Inc. (2.97K), less than Monopar Therapeutics Inc. (1.92), less than Applied Molecular Transport Inc. (7.80), less than Scopus BioPharma Inc. (5.41K), less than Magenta Therapeutics, Inc. (4.99), less than Marizyme, Inc. (0.05), less than Allena Pharmaceuticals, Inc. (14.64), less than null (0.04), less than null (2.11),

Build a custom stock screener for ChitogenX Inc. (CHNXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ChitogenX Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ChitogenX Inc. (CHNXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ChitogenX Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.